Average Co-Inventor Count = 5.83
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biogen Idec Ma Inc. (15 from 216 patents)
2. Morphic Therapeutic, Inc. (10 from 15 patents)
3. Biogen Ma Inc. (9 from 250 patents)
4. Merrimack Pharmaceuticals, Inc. (9 from 52 patents)
5. Sunesis Pharmaceuticals, Inc. (8 from 63 patents)
6. Millennium Pharmaceuticals Limited (4 from 850 patents)
7. Seagen Inc. (1 from 64 patents)
8. Als Therapy Development Institute (1 from 17 patents)
9. Siamab Therapeutics, Inc. (1 from 4 patents)
50 patents:
1. 12415796 - Inhibitors of (αv)(β6) integrin
2. 12221416 - Antagonists of human integrin α4β7
3. 12145935 - Inhibitors of (α-v)(β-6) integrin
4. 11827621 - Inhibitors of (α-v)(β-6) integrin
5. 11795167 - Inhibitors of (α-v)(β-6) integrin
6. 11571477 - Anti-VLA-4 antibodies
7. 11401330 - Glycan-interacting compounds and methods of use
8. 11384152 - Therapeutic anti-CD40 ligand antibodies
9. 11174228 - Antagonists of human integrin (α4)(β7)
10. 11083791 - Anti-VLA-4 antibodies
11. 11046669 - Inhibitors of (α-v)(β-6) integrin
12. 11046685 - Inhibitors of (α-v)(β-6) integrin
13. 11040955 - Inhibitors of (alpha-v)(beta-6) integrin
14. 10759756 - Antagonists of human integrin α4β7
15. 10577374 - Bruton's tyrosine kinase inhibitors